Tag: companion animal
Boehringer Ingelheim wins best new product award for Senvelgo
Senvelgo®, a recent innovation from Boehringer Ingelheim that makes treating diabetic cats simple, safe, and highly convenient, won the 2023 Animal Health Best New...
KENT acquires Lovitts for sustainable, customizable product development
FibreCycle, a subsidiary of KENT Pet Group, acquired Lovitts, an Australian manufacturer of high-quality companion animal nutrition. The purchase allows the major U.S. pet...
Avivagen announces approval in China, world’s largest commercial feed production market
Avivagen Inc. announced that OxC-betaTM, its oxidized carotenoid-based feed additive product has received approval for use in China. The approval comes as a result...
Neogen acquires animal genetic testing company Genetic Veterinary Sciences
Neogen has acquired companion animal genetic testing company Genetic Veterinary Sciences, Inc. (GVS). This acquisition will further expand the opportunities for Neogen's global genomics...
ADM to acquire Deerland Probiotics & Enzymes
Archer Daniels Midland (ADM) has agreed to purchase US-based Deerland Probiotics & Enzymes, a leading provider of probiotic and dietary supplements using probiotic, prebiotic,...
Kansas State, Elanco form strategic alliance to improve animal health
K-State University and Elanco have joined forces for a 5-year strategic alliance agreement for joint research and innovation to improve health of companion animal...
NEOGEN acquires CAPInnoVet, Inc.
NEOGEN Corporation announced that it has acquired Atlanta-based CAPInnoVet, Inc., a companion animal health company that provides pet medications to the veterinary market.
CAPInnoVet was...
Avivagen announces strategic changes to support growth in Asia and South America
Canada based Avivagen named Lesley Nernberg as technical sales and marketing consultant in Vietnam, Indonesia and South Korea. The company also terminated its distribution agreement of OxC-betaTM Livestock with São Paulo-based Look Chemicals Importacao E Exportacao LTDA in Brazil.
Avivagen announces new research publication for OxC-beta
Avivagen has announced upcoming research publication highlighting the benefits of OxC-betaTM livestock for broiler poultry. The study will be published soon in leading peer-reviewed journal Poultry Science.
Avivagen Inc. announces closing of $7.5 million bought beal unit offering
Avivagen Inc., a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announced that it closed its previously announced offering of 15,000,000 units of the Company (the “Units”) on a “bought deal” basis, at a price of $0.50 per Unit (the “Offering Price”) for aggregate gross proceeds of $7,500,000 (the “Offering”).
